588 related articles for article (PubMed ID: 28193689)
1. Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.
Furusho M; Ishii A; Bansal R
J Neurosci; 2017 Mar; 37(11):2931-2946. PubMed ID: 28193689
[TBL] [Abstract][Full Text] [Related]
2. Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood.
Ishii A; Furusho M; Macklin W; Bansal R
Glia; 2019 Jul; 67(7):1277-1295. PubMed ID: 30761608
[TBL] [Abstract][Full Text] [Related]
3. Role of ERK1/2 MAPK signaling in the maintenance of myelin and axonal integrity in the adult CNS.
Ishii A; Furusho M; Dupree JL; Bansal R
J Neurosci; 2014 Nov; 34(48):16031-45. PubMed ID: 25429144
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness.
Furusho M; Dupree JL; Nave KA; Bansal R
J Neurosci; 2012 May; 32(19):6631-41. PubMed ID: 22573685
[TBL] [Abstract][Full Text] [Related]
5. Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
Ishii A; Furusho M; Dupree JL; Bansal R
J Neurosci; 2016 Jun; 36(24):6471-87. PubMed ID: 27307235
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.
Bryant MR; Marta CB; Kim FS; Bansal R
Glia; 2009 Jul; 57(9):935-46. PubMed ID: 19053057
[TBL] [Abstract][Full Text] [Related]
7. The Akt-mTOR Pathway Drives Myelin Sheath Growth by Regulating Cap-Dependent Translation.
Fedder-Semmes KN; Appel B
J Neurosci; 2021 Oct; 41(41):8532-8544. PubMed ID: 34475201
[TBL] [Abstract][Full Text] [Related]
8. ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination.
Ishii A; Fyffe-Maricich SL; Furusho M; Miller RH; Bansal R
J Neurosci; 2012 Jun; 32(26):8855-64. PubMed ID: 22745486
[TBL] [Abstract][Full Text] [Related]
9. G(i)α proteins exhibit functional differences in the activation of ERK1/2, Akt and mTORC1 by growth factors in normal and breast cancer cells.
Wang Z; Dela Cruz R; Ji F; Guo S; Zhang J; Wang Y; Feng GS; Birnbaumer L; Jiang M; Chu WM
Cell Commun Signal; 2014 Feb; 12():10. PubMed ID: 24521094
[TBL] [Abstract][Full Text] [Related]
10. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.
Kendall RT; Lee MH; Pleasant DL; Robinson K; Kuppuswamy D; McDermott PJ; Luttrell LM
J Biol Chem; 2014 Sep; 289(38):26155-26166. PubMed ID: 25081544
[TBL] [Abstract][Full Text] [Related]
11. Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage.
Fortin D; Rom E; Sun H; Yayon A; Bansal R
J Neurosci; 2005 Aug; 25(32):7470-9. PubMed ID: 16093398
[TBL] [Abstract][Full Text] [Related]
12. Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination.
Lebrun-Julien F; Bachmann L; Norrmén C; Trötzmüller M; Köfeler H; Rüegg MA; Hall MN; Suter U
J Neurosci; 2014 Jun; 34(25):8432-48. PubMed ID: 24948799
[TBL] [Abstract][Full Text] [Related]
13. Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.
Ishii A; Furusho M; Bansal R
Glia; 2021 Oct; 69(10):2429-2446. PubMed ID: 34157170
[TBL] [Abstract][Full Text] [Related]
14. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.
Zheng M; Liu Z; Mana L; Qin G; Huang S; Gong Z; Tian M; He Y; Wang P
J Ethnopharmacol; 2021 Oct; 278():114264. PubMed ID: 34082015
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG
Kamali S; Rajendran R; Stadelmann C; Karnati S; Rajendran V; Giraldo-Velasquez M; Berghoff M
Brain Pathol; 2021 Mar; 31(2):297-311. PubMed ID: 33103299
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol Biosynthesis Supports Myelin Gene Expression and Axon Ensheathment through Modulation of P13K/Akt/mTor Signaling.
Mathews ES; Appel B
J Neurosci; 2016 Jul; 36(29):7628-39. PubMed ID: 27445141
[TBL] [Abstract][Full Text] [Related]
18. mTORC1 Is Transiently Reactivated in Injured Nerves to Promote c-Jun Elevation and Schwann Cell Dedifferentiation.
Norrmén C; Figlia G; Pfistner P; Pereira JA; Bachofner S; Suter U
J Neurosci; 2018 May; 38(20):4811-4828. PubMed ID: 29695414
[TBL] [Abstract][Full Text] [Related]
19. mTORC2 Loss in Oligodendrocyte Progenitor Cells Results in Regional Hypomyelination in the Central Nervous System.
Dahl KD; Almeida AR; Hathaway HA; Bourne J; Brown TL; Finseth LT; Wood TL; Macklin WB
J Neurosci; 2023 Jan; 43(4):540-558. PubMed ID: 36460463
[TBL] [Abstract][Full Text] [Related]
20. A Novel mTORC1-Dependent, Akt-Independent Pathway Differentiates the Gut Tropism of Regulatory and Conventional CD4 T Cells.
Chen LC; Nicholson YT; Rosborough BR; Thomson AW; Raimondi G
J Immunol; 2016 Aug; 197(4):1137-47. PubMed ID: 27402696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
